NIH and Lilly to generate public resource of approved and investigational medicines

Tuesday, March 13, 2012

Collaboration may make drug development pipelines more productive

The National Institutes of Health and Eli Lilly and Company will generate a publicly available resource to profile the effects of thousands of approved and investigational medicines in a variety of sophisticated disease-relevant testing systems, NIH announced today.